Page last updated: 2024-12-05

popop

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID15732
CHEMBL ID1533636
CHEBI ID52236
SCHEMBL ID75219
MeSH IDM0091406

Synonyms (57)

Synonym
oxazole, 2,2'-(1,4-phenylene)bis[5-phenyl-
oxazole, 2,2'-(1,4-phenylene)bis(5-phenyl-
unii-mdi740g2q0
nsc 24859
einecs 217-304-6
oxazole, 2,2'-p-phenylenebis(5-phenyl-
1,4-bis-2-(5-phenyloxazolyl)-benzene
mdi740g2q0 ,
1,4-bis(5-phenyloxazol-2-yl)benzene
oxazole,2'-(1,4-phenylene)bis[5-phenyl-
nsc-24859
oxazole,2'-p-phenylenebis[5-phenyl-
p-bis(5-phenyloxazol-2-yl)benzene
1,4-bis[2-(5-phenyloxazolyl)]benzene
2,2'-p-phenylenebis(5-phenyloxazole)
NSC24859 ,
popop
1806-34-4
NCI60_001983
5-phenyl-2-(4-(5-phenyl-1,3-oxazol-2-yl)phenyl)-1,3-oxazole
NCGC00013313
EU-0000145
1,4-bis(5-phenyl-2-oxazolyl)benzene, bioreagent, suitable for scintillation
NCI24859
NCISTRUC1_001243
NCISTRUC2_001142
NCGC00096430-01
CHEBI:52236 ,
2,2'-benzene-1,4-diylbis(5-phenyl-1,3-oxazole)
1,4-di(5-phenyl-2-oxazolyl)benzene
B0509
AKOS001483318
STK830350
5-phenyl-2-[4-(5-phenyl-1,3-oxazol-2-yl)phenyl]-1,3-oxazole
1,4-bis(5-phenyl-2-oxazolyl)benzene
CCG-37033
NCGC00013313-02
FT-0606786
SCHEMBL75219
DTXSID7061984
CHEMBL1533636
1,4-bis(2-(5-phenyloxazolyl))benzene
5-phenyl-2-[4-(5-phenyl-1,3-oxazol-2-yl)phenyl]-1,3-oxazole #
1,4-bis(5-phenyl-1,3-oxazol-2-yl)benzene
mfcd00005309
1,4-bis(5-phenyl-2-oxazolyl)benzene, suitable for scintillation, 98%
AS-65406
J-011535
Q414326
9(10h)-acridinone, 1,3-dimethyl-
1,4-bis(phenyl-2-oxazolyl)benzene
di(phenyl-5-oxazolyl-2)-1,4-benzene
2,2'-(1,4-phenylene)bis(5-phenyloxazole)
5,5'-diphenyl-2,2'-(p-phenylene)di-1,3-oxazole
D95270
CS-0217331
EN300-7369807
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
1,3-oxazoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
15-lipoxygenase, partialHomo sapiens (human)Potency0.25120.012610.691788.5700AID887
thyroid stimulating hormone receptorHomo sapiens (human)Potency3.98110.001318.074339.8107AID926; AID938
caspase-1 isoform alpha precursorHomo sapiens (human)Potency6.30960.000311.448431.6228AID900
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (40.00)18.7374
1990's2 (13.33)18.2507
2000's4 (26.67)29.6817
2010's2 (13.33)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 66.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index66.96 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index114.10 (26.88)
Search Engine Supply Index2.10 (0.95)

This Compound (66.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]